ALIGN TECHNOLOGY INC
NASDAQ: ALGN (Align Technology, Inc.)
Last update: 20 hours ago166.20
5.69 (3.54%)
Previous Close | 160.51 |
Open | 163.74 |
Volume | 1,275,514 |
Avg. Volume (3M) | 945,613 |
Market Cap | 12,231,920,640 |
Price / Earnings (TTM) | 29.57 |
Price / Earnings (Forward) | 20.58 |
Price / Sales | 3.88 |
Price / Book | 4.01 |
52 Weeks Range | |
Earnings Date | 30 Apr 2025 |
Profit Margin | 10.54% |
Operating Margin (TTM) | 18.18% |
Diluted EPS (TTM) | 5.62 |
Quarterly Revenue Growth (YOY) | 4.00% |
Quarterly Earnings Growth (YOY) | -16.30% |
Total Debt/Equity (MRQ) | 2.29% |
Current Ratio (MRQ) | 1.22 |
Operating Cash Flow (TTM) | 738.23 M |
Levered Free Cash Flow (TTM) | 622.33 M |
Return on Assets (TTM) | 6.87% |
Return on Equity (TTM) | 11.26% |
Market Trend
Short Term | Medium Term | ||
Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
Medical Instruments & Supplies (Global) | Mixed | Mixed | |
Stock | Align Technology, Inc. | Bearish | Bearish |
AIStockmoo Score
Analyst Consensus | 3.0 |
Insider Activity | NA |
Price Volatility | 5.0 |
Technical Moving Averages | 2.5 |
Technical Oscillators | -2.5 |
Average | 2.00 |
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients’ teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans. |
|
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
Investment Style | Mid Core |
% Held by Insiders | 6.83% |
% Held by Institutions | 89.64% |
52 Weeks Range | ||
Price Target Range | ||
High | 280.00 (Leerink Partners, 68.47%) | Buy |
Median | 265.00 (59.45%) | |
Low | 255.00 (Wells Fargo, 53.43%) | Buy |
Average | 266.17 (60.15%) | |
Total | 6 Buy | |
Avg. Price @ Call | 219.28 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Wells Fargo | 14 Feb 2025 | 255.00 (53.43%) | Buy | 206.77 |
Evercore ISI Group | 06 Feb 2025 | 260.00 (56.44%) | Buy | 218.38 |
Morgan Stanley | 06 Feb 2025 | 272.00 (63.66%) | Buy | 218.38 |
Piper Sandler | 06 Feb 2025 | 270.00 (62.45%) | Buy | 218.38 |
Jefferies | 23 Jan 2025 | 260.00 (56.44%) | Buy | 234.89 |
Leerink Partners | 06 Jan 2025 | 280.00 (68.47%) | Buy | 218.88 |
No data within this time range.
Date | Type | Details |
---|---|---|
10 Mar 2025 | Announcement | Align Technology Launches Align X-ray Insights, an AI Computer-Aided Detection Software, in the European Union and United Kingdom |
06 Mar 2025 | Announcement | Align Technology Announces Availability of Restorative Capabilities on Its Next Generation iTero Lumina™ Intraoral Scanner and New iTero Lumina™ Pro Dental Imaging System |
25 Feb 2025 | Announcement | Align Technology Announces $225 Million Open Market Repurchase |
10 Feb 2025 | Announcement | Invisalign® Palatal Expander System by Align Technology Now Available in Turkey for Skeletal and Dental Expansion in Growing Patients |
05 Feb 2025 | Announcement | Align Technology Announces Fourth Quarter and Fiscal 2024 Financial Results |
16 Jan 2025 | Announcement | Align Technology Announces NFL Quarterback Patrick Mahomes Joins the Invisalign Brand Smile Squad |
02 Jan 2025 | Announcement | Align Technology to Announce Fourth Quarter and 2024 Results on February 5, 2025 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |